Skip to main content
Toggle navigation
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Rababah, Abeer
Mayo Clinic
PII-102
-
PREDICTING THE EXPOSURE OF IRINOTECAN AND ITS ACTIVE METABOLITE (SN-38) IN CANCER PATIENTS USING PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING.
Abeer Rababah
Favorite
Ramesh, Shyam
University of Florida
PT-014
-
UTILIZING A DISEASE PROGRESSION MODEL TO DEVELOP A CLINICAL TRIAL SIMULATION TOOL THAT OPTIMIZES TRIAL DESIGN FOR AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE.
Shyam Ramesh
Favorite
RATH, SEEPRARANI
Rutgers, the State University of New Jersey
PII-108
-
STREAMLINING POTENCY ASSESSMENT OF TOPICAL CORTICOSTEROIDS USING VASOCONSTRICTOR ASSAY (VCA)
SEEPRARANI RATH
Favorite
Rhiani, Sweilem
Moderna, Inc.
PI-093
-
TRANSLATIONAL PHARMACOKINETIC/PHARMACODYNAMIC MODEL FOR NOVEL MRNA-MODALITY SUPPORTING ENZYME REPLACEMENT THERAPY.
Sweilem Rhiani
Favorite
Riselli, Andrew
University of California, San Francisco
PT-004
-
INTEGRATING BIOMARKERS AND PBPK MODELING TO UNCOVER THE MECHANISM OF A MULTI-TRANSPORTER DDI.
Andrew Riselli
Favorite
PWII-003
-
INTEGRATING BIOMARKERS AND PBPK MODELING TO UNCOVER THE MECHANISM OF A MULTI-TRANSPORTER DDI.
Andrew Riselli
Favorite
Roffel, Ad
ICON plc
PI-013
-
CONSIDERATIONS ON HUMAN ADME STUDIES AND PROPOSED DECISION TREE TOWARDS TAILORED STUDY DESIGNS.
Ad Roffel
Favorite
Rowland Yeo, Karen
Certara UK Ltd
PII-114
-
RELATIVE IMPACT OF CYP2D6 GENOTYPE PHENOTYPE ON EXPOSURE OF SSRIS DURING PREGNANCY: EXTRAPOLATION APPROACH USING RWD AND PBPK MODELLING
Karen Rowland Yeo
Favorite